Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000022885
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients using oral diabetic therapy or insulin therapy, those with mild renal dysfunction (male:s-Cre>1.5, female:s-Cre>1.3), those with severe infectin, those with severe trauma and those with severe liver dysfunction (AST and ALT: 3 times the normal levels) were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum glucose level after supper
- Secondary Outcome Measures
Name Time Method AUC over 140 mg/dl after supper 18-24, AUC over 140 mg/dl after supper 20-24, GLP-1 level at 30 minutes after load, IRI level at 2h after load